Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Front Immunol ; 12: 736692, 2021.
Article in English | MEDLINE | ID: mdl-34646271

ABSTRACT

Background: It is well documented that laboratory mice bred and maintained in ultra-hygienic specific pathogen-free (SPF) barriers display reduced richness and complexity of microbiota compared with wild mice. The laboratory mice profoundly lack lung parenchymal mast cells. Hence, we aimed to investigate the lung distribution of mast cells in free-living wild mice. Methods: Wild house mice were trapped in South-Eastern Norway and Hemtabad, West Bengal, India. C57BL/6 laboratory mice were bred in a purposefully built, closed environment with bedding material obtained from the natural environment in order to normalize the gut microbiota of these laboratory mice to that of the wild mice, and the offspring were collected for study at eight weeks of age. Results: Mast cells were easily identified at a substantial density in the lung parenchymal tissues of wild mice from both Norway and India, which stands in clear contrast to the rare distribution of lung parenchymal mast cells in the conventional laboratory SPF mice. Consistently, wild mice also expressed higher pulmonary levels of stem cell factor, a critical growth factor for mast cell survival. Higher levels of histamine were recorded in the lung tissues of the wild mice. Interestingly, "naturalized" C57BL/6 laboratory mice which spent their entire life in a semi-natural environment developed lung parenchymal mast cells at an appreciable density. Conclusion: Our observations support that environmental factors, possibly through modulation of microbiota, may impact the tissue distribution of mast cells in mouse lung parenchyma.


Subject(s)
Bacteria/immunology , Gastrointestinal Microbiome/immunology , Lung/immunology , Mast Cells/immunology , Animals , Animals, Wild , Environment , Female , Histamine/metabolism , Host-Pathogen Interactions , Lung/cytology , Lung/metabolism , Male , Mast Cells/metabolism , Mice, Inbred BALB C , Mice, Inbred C57BL , Specific Pathogen-Free Organisms
2.
Carbohydr Polym ; 171: 173-182, 2017 Sep 01.
Article in English | MEDLINE | ID: mdl-28578951

ABSTRACT

In this study, we developed bio-stimuli-responsive multi-scale hyaluronic acid (HA) nanoparticles encapsulated with polyamidoamine (PAMAM) dendrimers as the subunits. These HA/PAMAM nanoparticles of large scale (197.10±3.00nm) were stable during systematic circulation then enriched at the tumor sites; however, they were prone to be degraded by the high expressed hyaluronidase (HAase) to release inner PAMAM dendrimers and regained a small scale (5.77±0.25nm) with positive charge. After employing tumor spheroids penetration assay on A549 3D tumor spheroids for 8h, the fluorescein isothiocyanate (FITC) labeled multi-scale HA/PAMAM-FITC nanoparticles could penetrate deeply into these tumor spheroids with the degradation of HAase. Moreover, small animal imaging technology in male nude mice bearing H22 tumor showed HA/PAMAM-FITC nanoparticles possess higher prolonged systematic circulation compared with both PAMAM-FITC nanoparticles and free FITC. In addition, after intravenous administration in mice bearing H22 tumors, methotrexate (MTX) loaded multi-scale HA/PAMAM-MTX nanoparticles exhibited a 2.68-fold greater antitumor activity.


Subject(s)
Drug Carriers/chemistry , Drug Carriers/therapeutic use , Hyaluronic Acid/chemistry , Nanoparticles/chemistry , Nanoparticles/therapeutic use , Neoplasms/drug therapy , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Cell Proliferation/drug effects , Dendrimers , Drug Carriers/standards , Male , Methotrexate/chemistry , Methotrexate/pharmacology , Mice , Mice, Nude
3.
Nanomedicine ; 13(4): 1399-1410, 2017 05.
Article in English | MEDLINE | ID: mdl-28115251

ABSTRACT

Most nanoparticles (NPs) have difficulty deeply penetrating into tumor tissues. Here, we designed a spatially controlled multistage nanocarrier by encapsulating small polyamidoamine (PAMAM) dendrimers (~5 nm) within large gelatin NPs (~200 nm). This multistage nanocarrier is meant to be stable during systemic circulation and to leak through tumor vasculature walls by the enhanced permeation and retention (EPR) effect. Afterwards, this multistage nanocarrier release PAMAM dendrimers in response to the high matrix metalloproteinase-2 (MMP-2) enzymes in the tumor microenvironment, and further transport into tumor cells. In this study, the demonstrated high intracellular uptake and deep penetration into tumor model verified the effective enzymes-responsively and spatially controlled multistage penetration of these combined nanocarriers. In addition, these multistage nanocarrier were further loaded with anti-tumor drug methotrexate (MTX) and evaluated both in vitro and in vivo to investigate their anti-tumor effect, which demonstrated that this multistage nanocarrier hold great potential in improving anti-tumor efficiency.


Subject(s)
Carcinoma, Hepatocellular/drug therapy , Dendrimers/chemistry , Drug Delivery Systems , Liver Neoplasms/drug therapy , Matrix Metalloproteinase 2/metabolism , Nanoparticles/chemistry , Animals , Cell Line, Tumor , Drug Liberation , Gelatin/chemistry , Humans , Male , Methotrexate/pharmacology , Mice, Nude , Neoplasms, Experimental/drug therapy , Spheroids, Cellular/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...